drugset / Trial / NCT01991223

Dexmedetomidine for Catheter-related Bladder Discomfort

NCT01991223 ↗

Phase 4 Unknown 114 enrolled Seoul National University Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

To evaluate the efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort

Timeline

Start
2013-11
Primary completion
2014-11
Completion
2014-11

Outcome

Met primary endpoint

paper The incidence of CRBD was significantly higher in the control group at 0 (78 vs. 50%; P = 0.004) PMID 25485879 ↗

paper CONCLUSION: Intraoperative dexmedetomidine administration decreased the incidence and severity of early postoperative CRBD PMID 25485879 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.3 ug/kg —